Chemical inhibitors of AKAP 82 target the protein's role in scaffolding and localizing key signaling molecules within the cell. H-89, KT5720, and the Protein Kinase Inhibitor Peptide are potent inhibitors of Protein Kinase A (PKA), a molecule that AKAP 82 anchors to specific cellular locations to facilitate signal transduction. The inhibition of PKA by these chemicals disrupts its interaction with AKAP 82, thereby impairing the ability of AKAP 82 to localize PKA effectively. Similarly, St-Ht31 and the myristoylated PKI(14-22)amide function by binding to the PKA binding domain of AKAP 82. This action blocks the docking site and disrupts the normal anchoring of PKA by AKAP 82, preventing the proper assembly of PKA-mediated signaling complexes. Rp-cAMPS, as a competitive inhibitor of cAMP, acts by mimicking the natural ligand of PKA without activating the kinase, thus indirectly preventing AKAP 82 from playing its role in PKA localization and downstream signaling.
Additionally, Myristoylated PKI directly inhibits PKA, which in turn means that AKAP 82 is unable to perform its scaffolding function for PKA, impacting the signaling pathways reliant on this localization. The MLCK Inhibitor Peptide 18 acts on myosin light-chain kinase (MLCK), a kinase that plays a role in cytoskeletal dynamics. Since AKAP 82 is involved in organizing the cytoskeleton during processes like sperm motility, inhibiting MLCK indirectly impacts the ability of AKAP 82 to participate in these cellular rearrangements. Go6976, Chelerythrine, and Bisindolylmaleimide I are inhibitors of Protein Kinase C (PKC). These chemicals interfere with the phosphorylation events that AKAP 82 may facilitate. By inhibiting PKC, the phosphorylation of AKAP 82's substrates is compromised, which in turn hinders AKAP 82's function in organizing signaling complexes where PKC-mediated phosphorylation is required. Through these mechanisms, each of the chemicals contributes to the functional inhibition of AKAP 82 by disrupting its interactions with key signaling proteins, thereby impairing the protein's ability to orchestrate vital cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
KT5720 is a selective inhibitor of PKA. By inhibiting PKA, it disrupts the association of PKA with AKAP 82, thereby inhibiting the function of AKAP 82 in scaffolding PKA at specific cellular locations and thus indirectly inhibiting AKAP 82's function. | ||||||
PKA Inhibitor IV | 99534-03-9 | sc-3010 | 0.5 mg | $97.00 | 17 | |
This peptide inhibitor of PKA can disrupt the interaction between PKA and AKAP 82, thus functionally inhibiting AKAP 82 by preventing it from anchoring PKA to designated subcellular locations, which is crucial for the role of AKAP 82 in cellular signaling. | ||||||
PKI (14-22) amide (myristoylated) | 201422-03-9 | sc-471154 | 0.5 mg | $135.00 | 2 | |
Myristoylated PKI is a potent inhibitor of PKA. By inhibiting PKA, it disrupts the functional interaction between PKA and AKAP 82, thereby indirectly inhibiting the scaffolding function of AKAP 82. | ||||||
Rp-cAMPS | 151837-09-1 | sc-24010 | 1 mg | $203.00 | 37 | |
Rp-cAMPS is a cAMP analog that acts as a competitive inhibitor of cAMP-dependent PKA. By inhibiting PKA, Rp-cAMPS indirectly inhibits the function of AKAP 82 by preventing its role in anchoring PKA to specific locations, therefore inhibiting the signaling pathways regulated by AKAP 82. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a potent inhibitor of Protein Kinase C (PKC), which can phosphorylate substrates that interact with AKAP 82. Inhibiting PKC can disrupt these phosphorylation events, indirectly inhibiting AKAP 82's role in anchoring proteins whose function depends on PKC-mediated phosphorylation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a selective inhibitor of PKC. By inhibiting PKC, it may interfere with the phosphorylation of substrates of AKAP 82, thus indirectly inhibiting the functional role of AKAP 82 in scaffolding proteins that are regulated by PKC-dependent phosphorylation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is another PKC inhibitor that can prevent the phosphorylation of proteins associated with AKAP 82. By doing so, it could functionally inhibit AKAP 82's ability to scaffold PKC and its substrates at specific cellular sites, disrupting the signaling pathways mediated by AKAP 82. | ||||||